Elesta announces that the Chinese regulatory authority National Medical Products Administration (NMPA) has approved EchoLaser for use in prostatic diseases. This approval is a major achievement and represents a great opportunity for Elesta (distributed in China by... Leggi tutto
Excellent surgery, at the Villa Azzurra Nursing Home
“…. Medicine is a field in which every innovation involves improvements for the whole human race, so every opportunity to update their knowledge can only be an investment for the common well-being and for their personal growth. “ The EchoLaser SoracteLite... Leggi tutto
EchoLaser SoracteLite TPLA: now on RAI national TV
TV coverage of EchoLaser for BPH (Benign Prostatic Hyperplasia) on RAI, Italian state television. Prof. Pierluigi Bove illustrates the benefits of this new and fast emerging technology. Prof. Bove was one of the first users of EchoLaser and is the principal... Leggi tutto
SoracteLite in UK
Ideal Medical Solutions, exclusive distributor of Elesta #EchoLaser in UK/IRE, has launched a campaign to increase awareness on Benign Prostatic Hyperplasia, a disease which affects 1 out of 2 males above 50 years. Patients can scan a QR Code and book a free... Leggi tutto
SIU 2022
Elesta is gaining visibility i n the Urology space: we are sponsor of the SIU (Società Italiana di Urologia) national congress in Riccione these days. EchoLaser is a game changer for the outpatient, non surgical treatment of Benign Prostatic Hyperplasia. Leggi tutto
